Webinar: Cell Therapy Development for Solid Tumors
Please join us for this webinar, during which we will highlight a variety of assays to support the development of cell therapies for solid tumors.
Improving the viral plaque assay speed, sensitivity and robustness using imaging cytometry
Improved fluorescent plaque assay method using fluorescently-labeled antibodies and the use of the Celigo image cytometer.
Improve Seahorse XF results using direct cell counting
Improve Seahorse XF results using direct cell counting. An important step in performing SeahorseTM XF cell metabolism analysis is normalization of the resultant data.
Video Workflow-at-a-Glance: NK Cell-Mediated Cytotoxicity Assay
Directly image and count calcein AM-labeled target cells in a 96-well plate using Celigo image cytometer. Concurrent imaging and analysis in 8 minutes.
Video Workflow-at-a-Glance: Seahorse™ Normalization Assay
Celigo Image Cytometer provides a fast, effective, and cell stress-free technique to count cells plated onto uncoated or coated culture plates.
Normalizing Seahorse™ XF Data with Label-Free Cell Counting
How to use Celigo image cytometry to normalize Seahorse™ XF data and eliminate time-consuming protein-based process.
Evaluating Anticancer Drug Compounds using Image Cytometry
Image-based, automated analysis of 3-D tumor spheroids in microwell plates is becoming standard practice for the evaluation of anticancer drug compounds.
Automated Cell Counters: Accurate, Reproducible Cell Counts for the Entire Cell Therapy Workflow
Cellometer automated cell counters have been facilitating CAR T manufacturing with accurate cell counting and analysis since 2010.
Celigo Provides Image-Based Proof of Single-Cell Clonality
The FDA identifies clonality as one of the most crucial steps in guaranteeing cell line quality and safety. The Celigo Image Cytometer makes single cell sorting easy.
Poster: High-throughput immune complex analysis method for CAR T cell-mediated cytotoxicity using the Celigo Image Cytometer
Download our Poster Abstract: Cancer immunotherapy has been gaining momentum in the field of cancer research. Specifically, Chimeric Antigen Receptor (CAR) T cell technology have introduced new methods to combat cancer. Direct cell-mediated cytotoxicity assays are required to assess the killing capability of the engineered CAR T cells. Traditionally, these assays are conducted by measuring the amount of released Chromium, calcein AM, or LDH molecules after the target cancer cells are killed with CAR T cells. These methods require a large amount of target cells which may not be ideal when working with donor primary samples. Additionally, they cannot [...]